Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Erika Sifuentes"'
Autor:
Maryam Vaseghi-Shanjani, Pariya Yousefi, Mehul Sharma, Simran Samra, Erika Sifuentes, Stuart E. Turvey, Catherine M. Biggs
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
Transcription factors (TFs) are critical components involved in regulating immune system development, maintenance, and function. Monogenic defects in certain TFs can therefore give rise to inborn errors of immunity (IEIs) with profound clinical impli
Externí odkaz:
https://doaj.org/article/a079a5fbb374484fafb39ebb7c65be76
Autor:
Cynthia Villarreal-Garza, Ana S. Ferrigno, Alejandro Aranda-Gutierrez, Paul H. Frankel, Nora H. Ruel, Alan Fonseca, Steven Narod, Yanin Chavarri-Guerra, Erika Sifuentes, Maria Cristina Magallanes-Hoyos, Josef Herzog, Danielle Castillo, Rosa M. Alvarez-Gomez, Alejandro Mohar-Betancourt, Jeffrey N. Weitzel
Publikováno v:
Cancer Res Commun
The presence of BRCA pathogenic variants (PV) in triple-negative breast cancer (TNBC) is associated with a distinctive genomic profile that makes the tumor particularly susceptible to DNA-damaging treatments. However, patients with BRCA PVs can devel
Publikováno v:
Reference Module in Food Science ISBN: 9780081005965
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71675896a76837c29962189fc8433c8c
https://doi.org/10.1016/b978-0-323-96018-2.00008-0
https://doi.org/10.1016/b978-0-323-96018-2.00008-0
Publikováno v:
Paediatric rheumatology.
Background Pediatric-onset Systemic Erythematosus Lupus (pSLE) is known to be more aggressive than adult-onset SLE. The disease is extremely rare under the age of 5 years and with severe course. Another big difference is the association of pSLE with
Autor:
Cynthia Villarreal-Garza, Santiago Ruano, Enrique Bargallo-Rocha, Alberto Alvarado-Miranda, Claudia Hs Caro-Sánchez, Alejandro Mohar, Fernando Lara-Medina, Enrique Soto-Perez-de-Celis, Noel Castañeda-Soto, Claudia Arce-Salinas, Erika Sifuentes, Yanin Chavarri-Guerra, Berenice Baez-Revueltas
Publikováno v:
The Breast. 24:218-223
Evidence regarding the outcomes of Hispanic women with breast cancer is lacking. We analyzed women with HER2+ disease treated with trastuzumab-based neoadjuvant chemotherapy in Mexico.244 patients were included. Outcomes were compared between patient
Autor:
Robert Royer, Jeffrey N. Weitzel, Maria Cristina Magallanes-Hoyos, D. Castillo, J. Herzog, Cynthia Villarreal-Garza, Rosa María Álvarez-Gómez, Marcia Llacuachaqui, Luis A. Herrera, Lenny Gallardo, Erika Sifuentes, Fernando Lara-Medina, Alejandro Mohar, Mohammad R. Akbari, Steven A. Narod
Publikováno v:
Breast cancer research and treatment. 150(2)
Various guidelines recommend that women with triple-negative breast cancer should be tested for BRCA1 mutations, but the prevalence of mutations may vary with ethnic group and with geographic region, and the optimal cutoff age for testing has not bee
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 66(1)
To test in two groups of physicians-in-training a simplified questionnaire exploring their acceptance of Physician Assisted Death (PAD), Therapy Withdrawal upon family request (WD), and Personalized PAD (PPAD) on whether the participant would seek PA
Publikováno v:
Archives of medical research. 44(6)
Background and Aims To explore opinions of young residents and medical students on physician-assisted death (PAD). Methods A questionnaire was answered by 140 residents at the beginning of their residency and 99 third- or fourth-year medical students
Autor:
Lenny Gallardo, Erika Sifuentes, Rosa María Álvarez-Gómez, Marcia Llacuachaqui, Josef Herzog, Rob Royer, Steven A. Narod, Fernando Lara-Medina, Jeffrey N. Weitzel, Cynthia Villarreal-Garza, Maria Cristina Magallanes-Hoyos, Danielle Castillo, Luis A. Herrera
Publikováno v:
Journal of Clinical Oncology. 32:1522-1522
1522 Background: Previous studies have shown that the prevalence of BRCA mutations among young TNBC patients is elevated. Current guidelines recommend that women ≤60 years with TNBC be referred for...
Autor:
Erika Sifuentes, Enrique Soto-Perez-de-Celis, Yanin Chavarri Guerra, Cynthia Villarreal-Garza, Jose Antonio Acevedo, F. Berenice Baez-Revueltas, Fernando Lara-Medina, Santiago Ruano
Publikováno v:
Journal of Clinical Oncology. 31:e11533-e11533
e11533 Background: The most accurate definition of pathologic complete response (pCR) in HER2+ BC patients (pts) receiving T-based neoadjuvant chemotherapy associated with improved DFS is controversial, particularly regarding the role of residual duc